Mihalopoulos, M.; Dovey, Z.; Archer, M.; Korn, T.G.; Okhawere, K.E.; Nkemdirim, W.; Funchess, H.; Rambhia, A.; Mohamed, N.; Kaplan, S.A.;
et al. Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer. Cancers 2020, 12, 2442.
https://doi.org/10.3390/cancers12092442
AMA Style
Mihalopoulos M, Dovey Z, Archer M, Korn TG, Okhawere KE, Nkemdirim W, Funchess H, Rambhia A, Mohamed N, Kaplan SA,
et al. Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer. Cancers. 2020; 12(9):2442.
https://doi.org/10.3390/cancers12092442
Chicago/Turabian Style
Mihalopoulos, Meredith, Zachary Dovey, Maddison Archer, Talia G. Korn, Kennedy E. Okhawere, William Nkemdirim, Hassan Funchess, Ami Rambhia, Nihal Mohamed, Steven A. Kaplan,
and et al. 2020. "Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer" Cancers 12, no. 9: 2442.
https://doi.org/10.3390/cancers12092442
APA Style
Mihalopoulos, M., Dovey, Z., Archer, M., Korn, T. G., Okhawere, K. E., Nkemdirim, W., Funchess, H., Rambhia, A., Mohamed, N., Kaplan, S. A., Mehrazin, R., Lundon, D., Tsao, C.-K., Badani, K. K., & Kyprianou, N.
(2020). Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer. Cancers, 12(9), 2442.
https://doi.org/10.3390/cancers12092442